Clearside Net Debt To E B I T D A from 2010 to 2024
CLSD Stock | USD 1.40 0.01 0.72% |
Net Debt To EBITDA | First Reported 2010-12-31 | Previous Quarter (0.57) | Current Value (0.54) | Quarterly Volatility 17.02214856 |
Check Clearside Biomedical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Clearside main balance sheet or income statement drivers, such as Depreciation And Amortization of 63.6 K, Interest Expense of 9.8 M or Other Operating Expenses of 35.5 M, as well as many exotic indicators such as Price To Sales Ratio of 8.35, Dividend Yield of 0.0 or Days Sales Outstanding of 8.24. Clearside financial statements analysis is a perfect complement when working with Clearside Biomedical Valuation or Volatility modules.
Clearside | Net Debt To E B I T D A |
Latest Clearside Biomedical's Net Debt To E B I T D A Growth Pattern
Below is the plot of the Net Debt To E B I T D A of Clearside Biomedical over the last few years. It is a leverage ratio that indicates a company's ability to pay off its incurred debt. It compares a company’s net debt (total debt minus cash) to its Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA). Clearside Biomedical's Net Debt To EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Clearside Biomedical's overall financial position and show how it may be relating to other accounts over time.
Net Debt To E B I T D A | 10 Years Trend |
|
Net Debt To E B I T D A |
Timeline |
Clearside Net Debt To E B I T D A Regression Statistics
Arithmetic Mean | 4.79 | |
Coefficient Of Variation | 355.56 | |
Mean Deviation | 8.20 | |
Median | 0.23 | |
Standard Deviation | 17.02 | |
Sample Variance | 289.75 | |
Range | 66.8512 | |
R-Value | 0.24 | |
Mean Square Error | 293.58 | |
R-Squared | 0.06 | |
Significance | 0.38 | |
Slope | 0.93 | |
Total Sum of Squares | 4,057 |
Clearside Net Debt To E B I T D A History
About Clearside Biomedical Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Clearside Biomedical income statement, its balance sheet, and the statement of cash flows. Clearside Biomedical investors use historical funamental indicators, such as Clearside Biomedical's Net Debt To E B I T D A, to determine how well the company is positioned to perform in the future. Although Clearside Biomedical investors may use each financial statement separately, they are all related. The changes in Clearside Biomedical's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Clearside Biomedical's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Clearside Biomedical Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Clearside Biomedical. Please read more on our technical analysis and fundamental analysis pages.
Last Reported | Projected for Next Year | ||
Net Debt To EBITDA | (0.57) | (0.54) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Clearside Biomedical is a strong investment it is important to analyze Clearside Biomedical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Clearside Biomedical's future performance. For an informed investment choice regarding Clearside Stock, refer to the following important reports:Check out the analysis of Clearside Biomedical Correlation against competitors. For information on how to trade Clearside Stock refer to our How to Trade Clearside Stock guide.You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Complementary Tools for Clearside Stock analysis
When running Clearside Biomedical's price analysis, check to measure Clearside Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clearside Biomedical is operating at the current time. Most of Clearside Biomedical's value examination focuses on studying past and present price action to predict the probability of Clearside Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clearside Biomedical's price. Additionally, you may evaluate how the addition of Clearside Biomedical to your portfolios can decrease your overall portfolio volatility.
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Transaction History View history of all your transactions and understand their impact on performance |
Is Clearside Biomedical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Clearside Biomedical. If investors know Clearside will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Clearside Biomedical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.55) | Revenue Per Share 0.132 | Quarterly Revenue Growth 56.5 | Return On Assets (0.38) | Return On Equity (13.10) |
The market value of Clearside Biomedical is measured differently than its book value, which is the value of Clearside that is recorded on the company's balance sheet. Investors also form their own opinion of Clearside Biomedical's value that differs from its market value or its book value, called intrinsic value, which is Clearside Biomedical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Clearside Biomedical's market value can be influenced by many factors that don't directly affect Clearside Biomedical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Clearside Biomedical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Clearside Biomedical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Clearside Biomedical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.